Greenwich LifeSciences GLSI
NASDAQ GLSI
$15.84 +0.21 (+1.34%)
As of: Sep 4, 2026 · 3:55 PM EDT

Greenwich LifeSciences (GLSI) Amortizatization of Intangibles (2019 - 2025)

Greenwich LifeSciences' (GLSI) quarterly Amortizatization of Intangibles came in at $876.0 in Q2 2025, down 2.99% YoY from $903.0 in Q2 2024, and down 2.99% on a QoQ basis from $903.0 in Q1 2025.

Analysis

Greenwich LifeSciences (GLSI) Amortizatization of Intangibles (2019 - 2025) Analysis & Trends

Greenwich LifeSciences (GLSI) has 7 years of Amortizatization of Intangibles data on file, last reported at $876.0 in Q2 2025.

  • Quarterly Amortizatization of Intangibles fell 2.99% year-over-year to $876.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $1779.0 (down 50.75% YoY) and the FY2025 annual result came in at $1779.0, down 50.75% from the prior year.
  • Amortizatization of Intangibles slipped to $876.0 in Q2 2025, from $903.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $903.0 in Q1 2021 to a low of $876.0 in Q2 2025.
  • A 5-year average of $901.5 and a median of $903.0 in 2021 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2021 — Amortizatization of Intangibles increased 0.22% — and 2025, when it retreated 2.99%.
  • Tracing GLSI's Amortizatization of Intangibles over 5 years: stood at $903.0 in 2021, then changed by 0.0% to $903.0 in 2022, then changed by 0.0% to $903.0 in 2023, then changed by 0.0% to $903.0 in 2024, then decreased by 2.99% to $876.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at $876.0 (Q2 2025), $903.0 (Q1 2025), and $903.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Greenwich LifeSciences 231.59 Mn 231.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 876.00
Mar 31, 2025 903.00
Dec 31, 2024 903.00
Sep 30, 2024 903.00
Jun 30, 2024 903.00
Mar 31, 2024 903.00
Dec 31, 2023 903.00
Sep 30, 2023 903.00
Jun 30, 2023 903.00
Mar 31, 2023 903.00
Dec 31, 2022 903.00
Sep 30, 2022 903.00
Jun 30, 2022 903.00
Mar 31, 2022 903.00
Dec 31, 2021 903.00
Sep 30, 2021 903.00
Jun 30, 2021 903.00
Mar 31, 2021 903.00
Dec 31, 2020 903.00
Sep 30, 2020 903.00